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doi:10.1Objective: CLOVES syndrome (congenital lipomatous overgrowth, vascular malformations, epidermal nevi,
and skeletal/scoliosis and spinal abnormalities) is a rare, complex overgrowth syndrome with serious morbidity.
In this communication we studied the presence of central and thoracic phlebectasia in patients with CLOVES syn-
drome and its clinical implications.
Methods: We conducted a comprehensive search of our databases at Children’s Hospital Boston over the last 10
years (1999–2008) for patients with CLOVES syndrome and central and thoracic phlebectasia. Medical records,
clinical photographs, and imaging studies of varying modalities were reviewed.
Results: Review of the clinical data and imaging studies of 12 patients with CLOVES syndrome documented the
presence of central and thoracic phlebectasia in 11 patients. Two patients had serious perioperative pulmonary
embolism, and 1 died.
Conclusions:Central and thoracic phlebectasia in patients with CLOVES syndrome is common and increases the
risk of pulmonary embolism. Aggressive prophylactic measures should be considered before major interventions.
(J Thorac Cardiovasc Surg 2010;140:459-63)There is a well-recognized risk of pulmonary embolism in
patients with overgrowth and complex vascular anomalies.
Although isolated and simple congenital dilatation of the
central or cervical veins (phlebectasia) is generally a benign
condition, these vascular anomalies in CLOVES syndrome
(congenital lipomatous overgrowth, vascular malforma-
tions, epidermal nevi, and skeletal/scoliosis and spinal ab-
normalities) can cause morbidity and mortality.
MATERIALS AND METHODS
The Committee on Clinical Investigation of Children’s Hospital Boston ap-
proved this study. The database of the Vascular Anomalies Center at Children’s
Hospital Boston was culled for patients with typical features of CLOVES syn-
drome who also had cross-sectional or angiographic cervicothoracic imaging.
Medical records and imaging studies were retrospectively reviewed.
Subjects who were not evaluated at our institution or lacked adequate
imaging studies were excluded. Demographic data, characteristics of the
lipomatous overgrowth, and vascular, cutaneous, and musculoskeletal fea-
tures were documented.
RESULTS
A cohort of 12 patients with the diagnosis of CLOVES
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Mstudies to permit adequate evaluation of the central veins.
Of those, 11 patients (7 male and 4 female patients; age
range, 5 months to 18 years) had phlebectasia of the thoracic
veins, central veins, or both. Table 1 and Figure 1 summarize
the major clinical findings.
The distribution of the affected veins in these 11 patients
is summarized in Table 2. Phlebectasia of the azygos-
hemiazygos system was the most common (9/11; Figure 2,
A), followed by the innominate (6/11, 3 bilateral; Figure 2,
B), subclavian (6/12, 4 bilateral; Figure 2, C), superior
vena caval (SVC; 3/13), lateral thoracic (2/12; Figure 2, C),
axillary (1/12), and jugular (1/12) veins. The inferior
vena cava (IVC) demonstrated focal megacava (1/11) and
absence of the IVC (because of agenesis or prior thrombosis
in 2/11 patients). There were 2 patients with azygos continu-
ation of the IVC, one of whom had an associated right aortic
arch.
Two patients with subclavian phlebectasia had a history
of symptomatic pulmonary embolism; both episodes oc-
curred intraoperatively, while the patient was in the prone
position. The first patient (no. 1 in Tables 1 and 2) was
a 16-year-old girl who had undergone resection of
a massive posterior thoracic lipomatous mass. During
general anesthesia and being positioned for a wound-
dressing change, she suddenly became cyanotic. She had se-
vere cardiorespiratory and hemodynamic compromise
caused by a massive bilateral pulmonary embolism from
a thrombus in a markedly ectatic axillary-subclavian vein.
Immediate sternotomy and pulmonary thrombectomy fol-
lowed by placement of an SVC filter. The postoperative pe-
riod was complicated by major neurologic deficits, infection,
and multiorgan failure culminating in death.rdiovascular Surgery c Volume 140, Number 2 459
Abbreviations and Acronyms
CLOVES ¼ congenital lipomatous overgrowth,
vascular malformations, epidermal
nevi, and skeletal/scoliosis and
spinal abnormalities
CT ¼ computed tomography
IVC ¼ inferior vena cava
SVC ¼ superior vena cava
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old boy who became hypotensive and hypoxic during spinal
exposure for correction of scoliosis. Nevertheless, he had
preoperative placement of a prophylactic IVC filter. The
procedure was aborted. Large pulmonary embolism was
detected on computed tomographic (CT) angiography.
There was also a clot in an ectatic lateral thoracic vein. An
SVC filter was placed, and the patient was anticoagulated.
His cardiorespiratory status normalized, he had no
neurologic sequelae, and his scoliosis stabilization
procedure has since been completed.
The third patient (no. 10 in Tables 1 and 2) was an
11-year-old boy who underwent resection of a large
truncal mass at an outside hospital. Retrospective review
of the CT scan showed a clot in an ectatic left subclavian
vein. The clinical significance of this clot and its temporal
relationship to the prior operation are uncertain.DISCUSSION
CLOVES syndrome is a recent addition to a group of
overgrowth disorders with complex vascular anomalies.
The cardinal features are truncal lipomatous masses, vascu-
lar malformations, and cutaneous and acral/musculoskeletal
anomalies.1,2 The increased risk of pulmonary embolism inTABLE 1. Summary of the clinical features of 11 patients with CLOVES
System Feature 1 2
General Age* 16 y 3y
Sex F F
Mosaic/asymmetric þ þ
Family history  
Lipomatous overgrowth Trunk þ þ
Vascular Lymphatic malformation þ þ
Capillary malformation þ þ
Venous malformation
Musculoskeletal Limbs: wide hands or feet þ þ
Limbs: ‘‘sandal-gap’’ deformity  NA
Limbs: macrodactyly  þ
Limbs: asymmetry þ NA
Scoliosis NA þ
NA, Data not available/not applicable; R, reported in the history and not confirmed by the
460 The Journal of Thoracic and Cardiovascular Surgcomplex vascular anomalies with overgrowth has been
reported, but pulmonary embolism has not been previously
recognized in patients with CLOVES syndrome. Patients
with Klippel–Trenaunay syndrome have combined
capillary–lymphatic–venous malformations and are at
higher risk for thromboembolic events than are those with
less extensive, isolated vascular malformations.3 The inci-
dence of venous thrombosis and pulmonary embolism in pa-
tients with Klippel–Trenaunay syndrome has been reported
to be 14% and 22%, respectively, with more than half of the
episodes occurring in the postoperative period.4 Pulmonary
embolism is the most common cause of premature death in
patients with Proteus syndrome, a rare disorder of dispropor-
tionate asymmetric overgrowth, cerebriform connective tis-
sue nevi, epidermal nevi, and vascular malformations.5
Thromboembolism in patients with Proteus syndrome is
analogous to that in CLOVES syndrome; that is, it occurs
in the perioperative setting and affects a similar age group.6,7
Phlebectasia of the major central veins is a rare congenital
anomaly usually affecting the internal jugular vein.8 The co-
existence of anomalous lymphatic and venous channels can
be explained by a common embryonic precursor of these 2
vascular lineages.9,10 Joseph and colleagues10 reviewed
the CT scans of 11 patients who had lymphatic malformation
of the mediastinum with variable extension into the neck and
axilla. Five of the 11 had gross dilatation of the SVC, and
a sixth patient had aneurysmal expansion of the left innom-
inate and jugular veins. Cervical lymphatic malformations
can also be associated with intracranial dural venous anom-
alies, such as persistent falcine sinus, underdeveloped supe-
rior sagittal sinus, and prominent occipital sinus.11,12
Upper extremity deep venous thrombosis, as occurred in 3
of our patients, accounts for about 14% of all pulmonary
emboli and can be precipitated by vigorous exercise, trauma,
or anatomic compression, although in many patients no
thrombogenic cause can be identified.13 Anticoagulation issyndrome and central phlebectasia
Patient no.
3 4 5 6 7 8 9 10 11
10 mo 8 y 5 mo 18 y 8 y 5 mo 18 y 11 y 10 mo
F M M F M M M M M
þ þ þ þ þ þ þ þ þ
        
þ þ þ þ þ þ þ þ þ
þ þ þ NA þ þ þ þ þ
R NA þ þ þ þ NA NA þ
summarized in table 2
þ NA þ þ NA þ þ þ þ
NA NA þ NA NA NA þ þ NA
þ þ NA þ þ þ þ NA NA
NA NA þ þ NA þ þ þ þ
NA NA þ þ  þ þ þ 
authors. *At the time of the first evaluation at our institution.
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FIGURE 1. Large bilateral truncal fatty masses with bilateral distribution partially covered by capillary malformations (port-wine stain; A). The hands are
asymmetrically wide and overgrown with increased interdigital spaces (B) and macrodactyly primarily affecting the left third and fourth fingers (C). The
photograph in panel D shows the typical broad feet and ‘‘sandal-gap’’ deformity.
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Mthe mainstay of treatment; additional interventions are
reserved for selected patients.14 In addition, the short-term
effectiveness and safety of an SVC filter in the treatment
of upper extremity deep venous thrombosis has been well
documented.15
Thromboembolism in patients with CLOVES syndrome
can be explained, at least in part, by stagnant flow in an ec-
tatic thoracic vein, central vein, or both. We recommend
contrast-enhanced cross-sectional imaging of the chest andThe Journal of Thoracic and Caabdomen (with special attention to the venous anatomy) in
patients with CLOVES syndrome before any invasive proce-
dure. The venous system of the extremities and chest wall
can be reliably examined with ultrasonography or ascending
venography.
Venous ectasia, particularly in the neck and upper extrem-
ity, is generally believed to be an isolated finding of little, if
any, clinical significance.16 Nevertheless, 2 patients with
CLOVES syndrome in our cohort had serious pulmonaryrdiovascular Surgery c Volume 140, Number 2 461
TABLE 2. Phlebectasia in 11 patients with CLOVES syndrome
No. SVC IVC Innominate Azygos/hemiazygos Jugular Axillary Subclavian Lateral thoracic Azygos continuation
1   R þ NA B B B 
2 þ NA B þ  NA B  *
3   B NA  NA B NA NA
4    þ  NA   NA
5    þ     
6     L NA L  
7  y  þ     
8  z B þ NA NA B B þ
9   R* þ  NA R*  
10 þ x  þ  NA  NA þ
11 þ  R þ  NA   
SVC, Superior vena cava; IVC, inferior vena cava; R, right; NA, data not available/not applicable; B, bilateral; L, left. *Possibly present/suggested on imaging study. yDilated su-
prarenal inferior vena cava. zNo iliac vein or inferior vena cava seen (except for intrahepatic inferior vena cava). xAbsent inferior vena cava.
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Membolism, with 1 fatality; both patients had unusual phle-
bectasia. The intraoperative prone position in patients with
innominate–subclavian phlebectasia is especially danger-
ous. Thus we propose that phlebectasia is the principal im-
plicated factor predisposing to thrombosis. Sluggish flow
within thoracic ectatic veins is likely exacerbated in theFIGURE 2. A, Enhanced computed tomographic scan through superior mediast
chest wall (white arrow) and posterior mediastinum (black arrow). B, The left inno
lymphatic malformation. C, Venogram of the left upper extremity showing mark
with a relatively normal innominate vein.
462 The Journal of Thoracic and Cardiovascular Surgprone position because of decreased venous return, depen-
dency, and direct compression. Interestingly, both patients
with thromboembolism had an unusual distribution of the
ectatic veins involving the axillary–subclavian veins and
the lateral thoracic vein. The clinical significance of phlebec-
tasia of the azygos venous system is unclear.inum. The azygos vein is ectatic (curved arrow). Note the overgrowth of the
minate vein is markedly dilated (black arrows) and surrounded by mediastinal
ed phlebectasia of the axillary, subclavian, and lateral thoracic veins (arrow)
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Alomari et al Perioperative ManagementThere are 2 limitations in our study: the retrospective
design and the small sample. Ascertainment bias could
have resulted in overestimation of the frequency and risk
of phlebectasia in this cohort of patients with CLOVES
syndrome. Further studies are needed to substantiate our
findings.
In conclusion, the potentially serious association between
phlebectasia and thromboembolism in patients with
CLOVES syndrome should alert clinicians to strongly initi-
ate appropriate prophylactic measures, such as anticoagula-
tion and caval filtration, particularly in the perioperative
period. Central and thoracic phlebectasia in patients with
CLOVES syndrome should be considered one of the few
indications for placement of an SVC filter.
We thank Ms Kim Chalache and Ms Cindy Dube for their help in
collecting the data and preparing the manuscript.References
1. Sapp JC, Turner JT, van de Kamp JM, van Dijk FS, Lowry RB, Biesecker LG.
Newly delineated syndrome of congenital lipomatous overgrowth, vascular mal-
formations, and epidermal nevi (CLOVE syndrome) in seven patients. Am J Med
Genet. 2007;143A:2944-58.
2. Alomari AI. Characterization of a distinct syndrome that associates complex trun-
cal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of
CLOVES syndrome. Clin Dysmorphol. 2009;18:1-7.The Journal of Thoracic and Ca3. Huiras EE, Barnes CJ, Eichenfield LF, Pelech AN, Drolet BA. Pulmonary throm-
boembolism associated with Klippel-Trenaunay syndrome. Pediatrics. 2005;116:
e596-600.
4. Baskerville PA, Ackroyd JS, Lea Thomas M, Browse NL. The Klippel-Trenaunay
syndrome: clinical, radiological and haemodynamic features and management.
Br J Surg. 1985;72:232-6.
5. Cohen MM Jr. Proteus syndrome: an update. Am J Med Genet C Semin Med
Genet. 2005;137C:38-52.
6. Slavotinek AM, Vacha SJ, Peters KF, Biesecker LG. Sudden death caused
by pulmonary thromboembolism in Proteus syndrome. Clin Genet. 2000;5:
386-9.
7. Biesecker L. The challenges of Proteus syndrome: diagnosis and management.
Eur J Hum Genet. 2006;14:1151-7.
8. Siani A, Flaishman I, Schioppa A, Zaccaria A, Baldassarre E. Jugular venous phle-
bectasia: uncommon in children, anecdotal in adults. Am J Surg. 2008;195:419-20.
9. Makariou E, Pikis A, Harley EH. Cystic hygroma of the neck: association with
a growing venous aneurysm. AJNR Am J Neuroradiol. 2003;24:2102-4.
10. Joseph AE, Donaldson JS, Reynolds M. Neck and thorax venous aneurysm:
association with cystic hygroma. Radiology. 1989;170:109-12.
11. Gu¨relik M, Ozu¨m U, Erdog˘an H, Aslan A. Orbital lymphangioma and its
association with intracranial venous angioma. Br J Neurosurg. 2004;18:168-70.
12. Tada H, Takanashi J, Barkovich AJ, Kohno Y. Intracranial dural venous anoma-
lies in familial cervical cystic hygroma. Pediatr Neurol. 2005;32:50-2.
13. Linnemann B, Meister F, Schwonberg J, Schindewolf M, Zgouras D,
Lindhoff-Last E. Hereditary and acquired thrombophilia in patients with upper ex-
tremity deep-vein thrombosis. Results from the MAISTHRO registry. Thromb
Haemost. 2008;100:440-6.
14. Lee AY, Ginsberg JS. Venous thrombosis of the upper extremities. Curr Treat
Options Cardiovasc Med. 2001;3:207-14.
15. Usoh F, Hingorani A, Ascher E, Shiferson A, Tran V, Mark N, et al. Long-term
follow-up for superior vena cava filter placement. Ann Vasc Surg. 2008;23:350-4.
16. Yoon PJ, Messner AH. Lymphatic malformation with internal jugular phlebecta-
sia. Otolaryngol Head Neck Surg. 2001;124:579-80.rdiovascular Surgery c Volume 140, Number 2 463
P
M
